Responsibility of a Pharmaceutical Company on Medicine Safety (Case Study on Paracetamol Syrup)
top of page
Asian Institute of Research, Journal Publication, Journal Academics, Education Journal, Asian Institute
Asian Institute of Research, Journal Publication, Journal Academics, Education Journal, Asian Institute

Law and Humanities
Quarterly Reviews

ISSN 2827-9735

Judge Gavel
 Scales of Justice
City Crowds
People in Library
crossref
doi
open access

Published: 25 December 2023

Responsibility of a Pharmaceutical Company on Medicine Safety (Case Study on Paracetamol Syrup)

Yuwono Prianto, Della Savelya

Tarumanagara University, Indonesia

asia institute of research, journal of education, education journal, education quarterly reviews, education publication, education call for papers
pdf download

Download Full-Text Pdf

doi

10.31014/aior.1996.02.04.96

Pages: 185-193

Keywords: Poisoning, Paracetamol, Ethylene Glycol, Diethylene Glycol

Abstract

Cases of medicine poisoning derived from paracetamol syrup that is currently rampant have caused acute kidney failure in children. This is known because of the content of harmful substances contained in the medicine. The dangerous substances contained in the medicine are Ethylene Glycol and Diethylene Glycol. Paracetamol syrup poisoning cases have claimed many victims. Up to now, 269 victims have experienced acute kidney failure and 157 of them are declared dead. This article analyses the responsibility of pharmaceutical companies in securing medicine in cases that occur and how legal steps are to protect the interests of victims and their families. The research methods employed normative legal methods sourced from secondary data in the form of legal materials and non-legal materials. The qualitative approach is descriptive and the data collection is qualitative. Qualitative data analysis using the Miles and Huberman model where the narrative and secondary data are examined with analysis content. This case is caused by intentional or negligence on the part of the pharmaceutical company producing the medicine in the production process and carelessness in the packaging and distribution of these medicines. The Ministry of Health and the Food and medicine Supervisory Agency (BPOM) are also recognized for being careless in supervising and issuing proper distribution permits for these medicines. There must be a responsibility from the parties concerned to the victims and their families. The parties involved in this medicine poisoning case have absolute legal responsibility (strict liability) for the losses suffered by the victims.

References

Agustin, Sienny. (2022). “Mengenal Etilen Glikol dan Dietelen Glikol serta Dampaknya” [Get to know Ethylene Glycol and Diethylene Glycol and their impacts]. https://www.alodokter.com/mengenal-etilen-glikol-dan-dietilen-glikol-serta-dampaknya
Indonesia, BBC. (2022). “Kasus Gangguan Ginjal Akut, Bagaimana Pengawasan Kualitas Obat di Industri Farmasi Indonesia? [Cases of Acute Kidney Disorders, How to Monitor Drug Quality in the Indonesian Pharmaceutical Industry]”. https://www.bbc.com/indonesia/articles/cw87nggv18yo
Fatimarahma, Szalma. (2022). “BPOM Pidanakan Yarindo dan Unibebi Terkait Kasus Gagal Ginjal Akut [BPOM Criminalizes Yarindo and Unibebi Regarding Acute Kidney Failure Case]”. https://kabar24.bisnis.com/read/20221031/15/1593246/bpom-pidanakan-yarindo-dan-unibebi-terkait-kasus-gagal-ginjal-akut
Kahfi. (2022). “Ini Tanggapan Universal Pharmaceutical yang Dilaporkan BPOM Terkait Kasus Obat Sirop [This is Universal Pharmaceutical's Response Reported by BPOM Regarding the Syrup Case]”. https://ekonomi.bisnis.com/read/20221030/257/1592934/ini-tanggapan-universal-pharmaceutical-yang-dilaporkan-bpom-terkait-kasus-obat-sirop
Chaterine, Rahel Nada. (2022). “MENKES: Sejak 5 Obat Sirup Ditarik, Kasus Gagal ginjal Akut Turun Drastis [MINISTER OF HEALTH: Since 5 Syrup Medicines Were Withdrawn, Cases of Acute Kidney Failure Have Dropped Drastically]”. https://amp.kompas.com/nasional/read/2022/10/30/08240201/menkes-sejak-5-obat-sirup-ditarik-kasus-gagal-ginjal-akut-turun-drastis
Indonesia, CNN. (2022).“Update Kasus Gangguan Ginjal Akut di RI: 245 Pasien, 141 Meninggal [Update on Cases of Acute Kidney Disorders in RI: 245 Patients, 141 Died]”. https://www.cnnindonesia.com/nasional/20221024110446-20-864503/update-kasus-gangguan-ginjal-akut-di-ri-245-pasien-141-meninggal
Annur, Cindy Mutia. (2022). “Diduga Jadi Penyebab Gagal Ginjal Akut Ini Tren Impor Etilen Glikol RI Dari India [Suspected to be the Cause of Acute Kidney Failure, This is the Trend of Indonesian Ethylene Glycol imports from India]”. https://databoks.katadata.co.id/datapublish/2022/10/21/diduga-jadi-penyebab-ginjal-akut-ini-tren-impor-etilen-glikol-ri-dari-india
Deddy, et.all, (2022). “ Tanggung Jawab Hukum Pedagang Besar Farmasi Terhadap Distribusi Obat Generik Kepada Apotek [Legal Responsibility of Pharmaceutical Wholesalers for the Distribution of Generic Medicines to Pharmacies]” Jurnal Lex LATA, Vol.3 Nomor 3.
Emzir. (2010). Metodologi Penelitian Kualitatif Analisis Data [Qualitative Research Methodology Data Analysis.]. Jakarta: Rajawali Pers.
Erwin, Muhammad. (2019). Filsafat Hukum, Refleksi Kritis terhadap Hukum dan Hukum Indonesia (dalam dimensi ide dan aplikasi) [Legal Philosophy, Critical Reflection on Indonesian Law and Jurisprudence (in the dimensions of ideas and applications)]. Depok: Rajawali Pers.
Fauzan, Rahmad. (2022). “Paracetamol Obat Sirup Mengandung Etilen Glikol, Ini Jawaban Kemenperin [Paracetamol Syrup Contains Ethylene Glycol, This is the Ministry of Industry's Answer]”. https://ekonomi.bisnis.com/read/20221020/257/1589817/paracetamol obat-sirop-mengandung-etilen-glikol-ini-jawaban-kemenperin
Natalia, Fransisca. (2022). “Pasien Gangguan Ginjal Akut Bisa Tuntut Ganti Rugi [Patients with Acute Kidney Disorders Can Claim Compensation]”. https://www.kompas.tv/article/342487/korban-gangguan-ginjal-bisa-minta-ganti-rugi-ylki-pun-buka-posko-pengaduan
Nelwan, Audy. (2015). “Pengaturan Hukum Pengamanan Dan Penggunaan Sediaan Farmasi [Legal Regulations for Safeguarding and Use of Pharmaceutical Preparations]”, Lex Et Societatis, Vol. III, No. 10.
Mudin, Nabila. (2018). “Penjaminan Mutu dalam Pendistribusian Sediaan Farmasi [Quality Assurance in the Distribution of Pharmaceutical Preparations]”, Majalah Farmestika, Vol. 3 Nomor 1.
Mustakim, et.all, “Narrative : Implementasi Distribusi obat Yang Baik Diperdagangkan Besar Farmasi [Narrative: Implementation of Good Drug Distribution in Large Pharmaceutical Traders]”, Jurnal Surya Medika, Vol. 6 No. 2.
Muthiah, Aulia. (2018). Hukum Perlindungan Konsumen [Consumer Protection Law]. Yogyakarta: Pustaka Baru Press.
Noviardi. (2021). “Tanggung Jawab Pelaku Usaha Terhadap Standar mutu Kosmetik Bagi Konsumen Berdasarkan Undang- Undang Nomor 8 Tahun 1999 Tentang Perlindungan Konsumen [Responsibilities of Business Actors for Cosmetic Quality Standards for Consumers Based on Law Number 8 of 1999 concerning Consumer Protection]” Jurnal Selat, Vol. 8 No. 2.
Pinandhita, Vidya. (2022). “Teridentifikasi di 15 Sirup Obat RI, Kenapa Bisa Ada Cemaran Etilen Glikol? [Identified in 15 Indonesian Medicine Syrups, Why Can There Be Ethylene Glycol Contamination?]”. https://health.detik.com/berita-detikhealth/d-6357897/teridentifikasi-di-15-sirup-obat-ri-kenapa-bisa-ada-cemaran-etilen-glikol/2
Prata, I Putu Rusdi Eka, et.all. (2021). “Pelaksanaan Perlindungan Konsumen Obat- obatan dalam kefarmasian [Implementation of Consumer Protection for Medicines in Pharmacy]” Jurnal Interpretasi Hukum, Vol. 2 No. 1.
Putra, Antonius, Hartini Yustina. (2012).“Implementasi Cara Distribusi Obat Yang Baik Pada Pedagang Besar Farmasi di Yogyakarta [Implementation of Good Medicine Distribution Methods for Pharmaceutical Wholesalers in Yogyakarta]”, Jurnal Farmasi Indonesia, Vol. 6 No. 1.
Sampurna, Budi, et.all. (2005). Bioetik dan Hukum Kedokteran [Bioethics and Medical Law]. Jakarta: Pustaka Dwipar.
Soekanto, Soerjono & Mamudji, Sri. (2022). Penelitian Hukum Normatif [Normative Legal Research]. Depok: PT RajaGrafindo Persada.
Sompotan, Bryan. (2016). “Pemberlakuan Sanksi Pidana Terhadap Produksi Dan Sediaan Farmasi Yang Tidak Memiliki Izin Edar [Imposition of Criminal Sanctions on Pharmaceutical Production and Preparations That Don’t Have a Distribution Permit]” Jurnal Lex Administratum, Vol. IV, No 3.
Sutarno. (2014). Hukum Kesehatan [Health Law]. Malang: Setara Press.
Sucahyo, Nurhadi. (2022). “Pakar: Industri Farmasi Tak Mungkin Campurkan Bahan Berbahaya dalam Oba[Expert: Pharmaceutical Industry Cannot Mix Dangerous Ingredients in Medicines ] t”.https://www.voaindonesia.com/a/pakar-industri-farmasi-tak-mungkin-campurkan-bahan-berbahaya-dalam-obat-/6801588.html
Youtube Kompas TV. (2022). “Diduga Ada Tindak Pidana, 2 Perusahaan Farmasi Akan Diselidiki Terkait Kasus Gagal Ginjal Anak [Suspected of a crime, 2 pharmaceutical companies will be investigated regarding cases of child kidney failure]”. https://youtu.be/_qGIvJSEp7Y
Zahira, Nadya. (2022). “Kemendag Pertimbangkan Setop Impor Etilen Glikol Pemicu Gagal Ginjal [Ministry of Trade Considers Stopping Imports of Ethylene Glycol, which Triggers Kidney Failure]”. https://katadata.co.id/tiakomalasari/berita/63578810813e3/kemendag-pertimbangkan-setop-impor-etilen-glikol-pemicu-gagal-ginjal

bottom of page